Carrier screening in health-care workers treating patients with MDR strains

2018-07-06

Mark Loeb

Should the health-care personnel treating a patient infected with a multidrug-resistant strain undergo carrier screening? If yes, when should the tests be performed: on a regular basis in all staff or only in case of exposure?

Mark Loeb: There is really no evidence at this point that there is any real benefit to screening doctors, for example, who have been exposed to a patient, especially if they are using adequate infection control precautions.

See also

Screening for drug-resistant pathogens on admission Is it advisable to perform screening tests for certain drug-resistant pathogens in patients admitted to a hospital? If so, who should be tested? Should we perform such screening tests in patients with a history of documented drug-resistant bacterial strain infection?
H pylori: Antibiotic resistance vs population screening Should the risk of developing antibiotic resistance prevent us from population screening for Helicobacter pylori?
Patients at highest risk of C difficile infection What patients are at the highest risk of developing Clostridium difficile infection?
Can minor multidrug-resistant bacterial infection become life-threatening? Can multidrug-resistant bacterial strains become so widespread that even minor infections could develop into life-threatening conditions, as it used to be in the pre-antibiotic era?
Fluid resuscitation in the early management of septic shock What are the current guidelines for fluid resuscitation in the early management of patients with septic shock?
Antibiotic resistance: how to handle in clinical practice A lecture by Prof. Mark Loeb, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2016.

Carrier screening in health-care workers treating patients with MDR strains

Social Media